Evidence map›Paper›PMID 35300082›Full record

ArticleACS medicinal chemistry letters2022

Enantiopure Benzofuran-2-carboxamides of 1-Aryltetrahydro-β-carbolines Are Potent Antimalarials

Hanan Almolhim, Sha Ding, Joshua H Butler, Emily K Bremers, Grant J Butschek, Carla Slebodnick, Emilio F Merino, Zaira Rizopoulos, Maxim Totrov, Maria B Cassera and 1 more

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hanan AlmolhimDepartment of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, 1040 Drillfield Drive, Blacksburg, Virginia 24061, United States.
Sha DingDepartment of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, 1040 Drillfield Drive, Blacksburg, Virginia 24061, United States.
Joshua H ButlerDepartment of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, 120 Green Street, Athens, Georgia 30602, United States.
Emily K BremersDepartment of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, 120 Green Street, Athens, Georgia 30602, United States.ORCID https://orcid.org/0000-0002-9768-0211
Grant J ButschekDepartment of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, 120 Green Street, Athens, Georgia 30602, United States.
Carla SlebodnickDepartment of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, 1040 Drillfield Drive, Blacksburg, Virginia 24061, United States.ORCID https://orcid.org/0000-0003-4188-7595
Emilio F MerinoDepartment of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, 120 Green Street, Athens, Georgia 30602, United States.
Zaira RizopoulosMedicines for Malaria Venture, 1215 Geneva, Switzerland.
Maxim TotrovMolsoft LLC, 11999 Sorrento Valley Road, San Diego, California 92121, United States.
Maria B CasseraDepartment of Biochemistry and Molecular Biology and Center for Tropical and Emerging Global Diseases, University of Georgia, 120 Green Street, Athens, Georgia 30602, United States.ORCID https://orcid.org/0000-0001-6341-3169
Paul R CarlierDepartment of Chemistry and Virginia Tech Center for Drug Discovery, Virginia Tech, 1040 Drillfield Drive, Blacksburg, Virginia 24061, United States.ORCID https://orcid.org/0000-0002-6683-285X

Funding

Optimization of antimalarials targeting multiple life stages of the parasiteR01AI157445 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Paul R Carlier, Maria Belen Cassera · 2021 to 2026
$4.5M
Structure- and ligand-based design of new IspD-targeting antimalarialsR21AI128362 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI CARLIER, PAUL R · 2017 to 2018
$431k
NIAID NIH HHS R01 AI157445NIAID NIH HHS R21 AI128362
6 · The paper itself

Abstract

The tetrahydro-β-carboline scaffold has proven fertile ground for the discovery of antimalarial agents (e.g., MMV008138 (

Identifiers

PMID35300082
PMCPMC8919387

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.